Jiraporn Khorana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiraporn Khorana has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Apichat Tantraworasin
Clinical Surgical Research Center, Chiang Mai University, Chiang Mai 50200, Thailand
14 shared publications - Phichayut Phinyo
Department of Biomedical Informatics and Clinical Epidemiology (BioCE), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
10 shared publications - Jayanton Patumanond
Clinical Epidemiology and Clinical Statistics Unit, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand
8 shared publications - Tanyong Pipanmekaporn
Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
8 shared publications - Prangmalee Leurcharusmee
Department of Anesthesiology, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, Chiang Mai, Thailand -
7 shared publications - Artid Samerchua
Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand
4 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (5) , 505-514
Is age just a number? Causal modeling of recurrence risk in rectal cancer
Purpose: Young-onset rectal cancer (YORC) is increasingly common and often presents with aggressive histological features; however, its effect on recurrence remains uncertain. This study aimed to estimate the causal effect of age at diagnosis on recurrence in patients with rectal cancer using advanced causal inference methods.Methods: This multicenter retrospective cohort study was conducted at 2 university hospitals in Thailand. Patients diagnosed with rectal adenocarcinoma between 2013 and 2022 who underwent curative-intent treatment were included. The primary exposure was age at diagnosis, categorized as YORC (<50 years) or late-onset rectal cancer (LORC; ≥50 years). Confounders were prespecified using a directed acyclic graph and addressed using a confounder composite score. Age was also modeled as a continuous variable using natural splines. The primary outcome was cancer recurrence.Results: Among 585 patients, 116 (19.8%) had YORC and 469 (80.2%) had LORC. Patients with YORC had fewer comorbidities but more unfavorable histological features than those with LORC. Overall, recurrence occurred in 40.2% of patients and most commonly involved distant metastasis. The estimated average causal effect of age on recurrence was −6.5% (95% confidence interval, −16.6% to 3.5%; P=0.202), indicating that younger age was not associated with an increased risk of recurrence, although a protective effect was not confirmed. Natural spline modeling indicated a nonlinear increase in recurrence hazard with advancing age.Conclusion: Younger age at diagnosis was not associated with worse recurrence outcomes despite adverse pathological features, and a potential protective association could not be excluded.
- 31 October 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (5) , 505-514
Open AccessIs age just a number? Causal modeling of recurrence risk in rectal cancer
Purpose: Young-onset rectal cancer (YORC) is increasingly common and often presents with aggressive histological features; however, its effect on recurrence remains uncertain. This study aimed to estimate the causal effect of age at diagnosis on recurrence in patients with rectal cancer using advanced causal inference methods.Methods: This multicenter retrospective cohort study was conducted at 2 university hospitals in Thailand. Patients diagnosed with rectal adenocarcinoma between 2013 and 2022 who underwent curative-intent treatment were included. The primary exposure was age at diagnosis, categorized as YORC (<50 years) or late-onset rectal cancer (LORC; ≥50 years). Confounders were prespecified using a directed acyclic graph and addressed using a confounder composite score. Age was also modeled as a continuous variable using natural splines. The primary outcome was cancer recurrence.Results: Among 585 patients, 116 (19.8%) had YORC and 469 (80.2%) had LORC. Patients with YORC had fewer comorbidities but more unfavorable histological features than those with LORC. Overall, recurrence occurred in 40.2% of patients and most commonly involved distant metastasis. The estimated average causal effect of age on recurrence was −6.5% (95% confidence interval, −16.6% to 3.5%; P=0.202), indicating that younger age was not associated with an increased risk of recurrence, although a protective effect was not confirmed. Natural spline modeling indicated a nonlinear increase in recurrence hazard with advancing age.Conclusion: Younger age at diagnosis was not associated with worse recurrence outcomes despite adverse pathological features, and a potential protective association could not be excluded.
- Open Access
- 27 October 2026
- Published by Springer Nature in BMC Surgery
Clinical factors associated with pulmonary complications after blunt chest trauma: a retrospective cohort study
- 27 October 2026
- Published by Springer Nature in BMC Surgery
Open AccessClinical factors associated with pulmonary complications after blunt chest trauma: a retrospective cohort study
- 23 October 2026
- Published by Wiley in World Journal of Surgery
Surgical Versus Conservative Management for Adhesive Small Bowel Obstruction: A Systematic Review and Meta‐Analysis
Objectives: To compare the clinical outcomes of surgical versus conservative management for adhesive small bowel obstruction (ASBO) in adult and pediatric patients by evaluating clinical outcomes, including in‐hospital mortality, length of stay (LOS), in‐hospital complications, 5‐year recurrence, and 5‐year reoperation. Methods: PubMed, Scopus, and Embase databases were searched for all randomized controlled trials (RCTs) and observational studies until March 2, 2026. Both adult and pediatric studies were included. Risk of bias (ROB) was evaluated using the Cochrane Risk‐of‐Bias 2 (RoB2) tool for RCTs, and the ROBINS‐I tool for observational studies. A pairwise meta‐analysis used a random‐effects model to estimate the clinical outcomes. The odds ratio (OR) and mean difference (MD) were employed to analyze dichotomous and continuous outcomes, respectively, with heterogeneity assessed by the I 2 statistic. Results: 45 studies were included (9 prospective studies, 33 retrospective studies, and 3 RCTs), with a total of 205,717 patients with ASBO. Forty studies involved adults, and five involved pediatric patients. The surgical management may be associated with higher in‐hospital mortality (OR = 1.87; 95% CI 1.21–2.89; I 2 = 63.68%, p = 0.010, very low certainty), more in‐hospital complications (OR = 5.33; 95% CI 3.17–8.97; I 2 = 76.89%, p < 0.001, very low certainty), and longer LOS (MD = 4.10; 95% CI 3.44–4.76; I 2 = 98.81%, p < 0.001, very low certainty) compared with the conservative management. However, surgical management may be associated with a lower risk of 5‐year recurrence (OR = 0.41; 95% CI 0.30–0.56; I 2 = 78.44%, p < 0.001, low certainty) compared with conservative management. No statistically significant association was observed in 5‐year reoperation between the surgical and conservative management (OR = 0.73; 95% CI 0.22–2.49; I 2 = 21.28%, p = 0.620, very low certainty). Conclusions: Surgical management may be associated with a lower risk of 5‐year recurrence in patients with ASBO but may be associated with higher in‐hospital mortality, more in‐hospital complications, and a longer length of stay. However, these findings should be interpreted with caution because of substantial heterogeneity and risk of bias.
- 23 October 2026
- Published by Wiley in World Journal of Surgery
Surgical Versus Conservative Management for Adhesive Small Bowel Obstruction: A Systematic Review and Meta‐Analysis
Objectives: To compare the clinical outcomes of surgical versus conservative management for adhesive small bowel obstruction (ASBO) in adult and pediatric patients by evaluating clinical outcomes, including in‐hospital mortality, length of stay (LOS), in‐hospital complications, 5‐year recurrence, and 5‐year reoperation. Methods: PubMed, Scopus, and Embase databases were searched for all randomized controlled trials (RCTs) and observational studies until March 2, 2026. Both adult and pediatric studies were included. Risk of bias (ROB) was evaluated using the Cochrane Risk‐of‐Bias 2 (RoB2) tool for RCTs, and the ROBINS‐I tool for observational studies. A pairwise meta‐analysis used a random‐effects model to estimate the clinical outcomes. The odds ratio (OR) and mean difference (MD) were employed to analyze dichotomous and continuous outcomes, respectively, with heterogeneity assessed by the I 2 statistic. Results: 45 studies were included (9 prospective studies, 33 retrospective studies, and 3 RCTs), with a total of 205,717 patients with ASBO. Forty studies involved adults, and five involved pediatric patients. The surgical management may be associated with higher in‐hospital mortality (OR = 1.87; 95% CI 1.21–2.89; I 2 = 63.68%, p = 0.010, very low certainty), more in‐hospital complications (OR = 5.33; 95% CI 3.17–8.97; I 2 = 76.89%, p < 0.001, very low certainty), and longer LOS (MD = 4.10; 95% CI 3.44–4.76; I 2 = 98.81%, p < 0.001, very low certainty) compared with the conservative management. However, surgical management may be associated with a lower risk of 5‐year recurrence (OR = 0.41; 95% CI 0.30–0.56; I 2 = 78.44%, p < 0.001, low certainty) compared with conservative management. No statistically significant association was observed in 5‐year reoperation between the surgical and conservative management (OR = 0.73; 95% CI 0.22–2.49; I 2 = 21.28%, p = 0.620, very low certainty). Conclusions: Surgical management may be associated with a lower risk of 5‐year recurrence in patients with ASBO but may be associated with higher in‐hospital mortality, more in‐hospital complications, and a longer length of stay. However, these findings should be interpreted with caution because of substantial heterogeneity and risk of bias.
- 8 October 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Early Outcomes of Physician-Modified Endurant Limbs vs Iliac Branch Devices in Narrow Common Iliac Arteries: A Retrospective Cohort Pilot Study
Objectives: To evaluate the feasibility and short-term outcomes of physician-modified Endurant limbs (PMEGs) for internal iliac artery (IIA) preservation in patients with narrow common iliac artery (CIA) anatomy, with descriptive comparison to commercially available iliac branch devices (IBDs). Methods: This retrospective multicenter pilot study included 20 consecutive patients with a CIA bifurcation diameter ≤18 mm who underwent endovascular aneurysm repair with preservation of at least 1IIA between January 2023 and December 2025. Ten patients were treated with PMEG and 10 with commercially available IBDs. Primary outcomes were technical success and IIA branch patency. Secondary outcomes included operative time, back-table modification time, endoleaks, reinterventions, and perioperative outcomes. Results: Technical success was achieved in all patients. Internal iliac artery branch patency was 100% at 1 and 3 months in both groups and remained 100% in the PMEG group vs 90% in the IBD group at 12 months. No type I/III endoleaks or iliac-related reinterventions occurred. Operative time was similar between groups, while mean PMEG modification time was 61.5 ± 26.4 minutes. No modification-related complications or procedure-related mortality occurred. Conclusions: The PMEG appears to be a feasible option for IIA preservation in patients with narrow iliac anatomy, demonstrating favorable early outcomes. Given the pilot design, small sample size, and limited follow-up, these findings should be interpreted cautiously and require validation in larger prospective studies. Clinical Impact: PMEGs may be a feasible option for IIA preservation in patients with narrow CIA anatomy when standard IBDs are limited by profile or availability. This approach may expand endovascular options in selected cases, emphasizing careful planning and technical flexibility. Given the small sample size, these findings warrant cautious interpretation and validation in larger studies.
- 8 October 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Early Outcomes of Physician-Modified Endurant Limbs vs Iliac Branch Devices in Narrow Common Iliac Arteries: A Retrospective Cohort Pilot Study
Objectives: To evaluate the feasibility and short-term outcomes of physician-modified Endurant limbs (PMEGs) for internal iliac artery (IIA) preservation in patients with narrow common iliac artery (CIA) anatomy, with descriptive comparison to commercially available iliac branch devices (IBDs). Methods: This retrospective multicenter pilot study included 20 consecutive patients with a CIA bifurcation diameter ≤18 mm who underwent endovascular aneurysm repair with preservation of at least 1IIA between January 2023 and December 2025. Ten patients were treated with PMEG and 10 with commercially available IBDs. Primary outcomes were technical success and IIA branch patency. Secondary outcomes included operative time, back-table modification time, endoleaks, reinterventions, and perioperative outcomes. Results: Technical success was achieved in all patients. Internal iliac artery branch patency was 100% at 1 and 3 months in both groups and remained 100% in the PMEG group vs 90% in the IBD group at 12 months. No type I/III endoleaks or iliac-related reinterventions occurred. Operative time was similar between groups, while mean PMEG modification time was 61.5 ± 26.4 minutes. No modification-related complications or procedure-related mortality occurred. Conclusions: The PMEG appears to be a feasible option for IIA preservation in patients with narrow iliac anatomy, demonstrating favorable early outcomes. Given the pilot design, small sample size, and limited follow-up, these findings should be interpreted cautiously and require validation in larger prospective studies. Clinical Impact: PMEGs may be a feasible option for IIA preservation in patients with narrow CIA anatomy when standard IBDs are limited by profile or availability. This approach may expand endovascular options in selected cases, emphasizing careful planning and technical flexibility. Given the small sample size, these findings warrant cautious interpretation and validation in larger studies.
- 8 October 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Diagnostic Performance of Ultrasonographic Median Nerve Cross-Sectional Area for Carpal Tunnel Syndrome in Wheelchair Users With Spinal Cord Injury
Objective: To evaluate the diagnostic performance of ultrasonographic median nerve cross-sectional area (CSA-M) for carpal tunnel syndrome (CTS) in wheelchair users with spinal cord injury (SCI), and to identify clinically relevant diagnostic cutoff values. Design: Prospective, cross-sectional diagnostic accuracy study using registry data from Thai wheelchair users with SCI receiving outpatient rehabilitation care at a tertiary university hospital. Ultrasonographic CSA-M (index test) and electrodiagnostic studies (reference standard) were performed by blinded examiners. Results: Sixty-seven participants were included, of whom 25(37.3%) had CTS. Among 126 wrists analyzed, 42(33.3%) had electrodiagnostically confirmed CTS. Mean CSA-M was significantly larger in CTS compared with non-CTS wrists (14.4±4.4 vs. 10.7±3.3 mm²; P <0.001). The AuROC was 0.76(95% CI, 0.67–0.84). At a 10 mm² cutoff sensitivity was 90.5%, and specificity was 45.2%. At 15 mm², sensitivity was 33.3%, and specificity was 91.7%. Age, sex, and body mass index did not influence diagnostic performance. The wrist-to-forearm ratio showed comparable, but not superior, diagnostic performance to CSA-M. Conclusions: Ultrasonographic CSA-M demonstrates moderate diagnostic accuracy for CTS in wheelchair users with SCI. Lower cutoffs favor screening sensitivity, whereas higher cutoffs improve diagnostic specificity.
- 8 October 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Diagnostic Performance of Ultrasonographic Median Nerve Cross-Sectional Area for Carpal Tunnel Syndrome in Wheelchair Users With Spinal Cord Injury
Objective: To evaluate the diagnostic performance of ultrasonographic median nerve cross-sectional area (CSA-M) for carpal tunnel syndrome (CTS) in wheelchair users with spinal cord injury (SCI), and to identify clinically relevant diagnostic cutoff values. Design: Prospective, cross-sectional diagnostic accuracy study using registry data from Thai wheelchair users with SCI receiving outpatient rehabilitation care at a tertiary university hospital. Ultrasonographic CSA-M (index test) and electrodiagnostic studies (reference standard) were performed by blinded examiners. Results: Sixty-seven participants were included, of whom 25(37.3%) had CTS. Among 126 wrists analyzed, 42(33.3%) had electrodiagnostically confirmed CTS. Mean CSA-M was significantly larger in CTS compared with non-CTS wrists (14.4±4.4 vs. 10.7±3.3 mm²; P <0.001). The AuROC was 0.76(95% CI, 0.67–0.84). At a 10 mm² cutoff sensitivity was 90.5%, and specificity was 45.2%. At 15 mm², sensitivity was 33.3%, and specificity was 91.7%. Age, sex, and body mass index did not influence diagnostic performance. The wrist-to-forearm ratio showed comparable, but not superior, diagnostic performance to CSA-M. Conclusions: Ultrasonographic CSA-M demonstrates moderate diagnostic accuracy for CTS in wheelchair users with SCI. Lower cutoffs favor screening sensitivity, whereas higher cutoffs improve diagnostic specificity.
- Open Access
- 13 April 2026
- Published by MDPI AG in Pediatric Reports
- Vol. 18 (2) , 56
Comparison of Postoperative Outcomes of Duhamel and Transanal Endorectal Pull-Through in Hirschsprung Disease: A Propensity Score Study
Background/Objectives: Hirschsprung disease (HSCR) is a congenital condition characterized by absence of ganglion cells in the distal bowel. The principle of surgical treatment is resection of the aganglionic bowel with restoration of intestinal continuity. Several operative techniques have been developed. This study aimed to compare outcomes between the Duhamel procedure and transanal endorectal pull-through (TERPT) in Hirschsprung disease using propensity score-based methods. Methods: Hirschsprung patients who underwent Duhamel or TERPT from January 2006 to December 2021 were included. The primary outcome was a composite endpoint at 6 months comprising obstructive symptoms, fecal soiling, or Hirschsprung-associated enterocolitis. Propensity scores were estimated via logistic regression incorporating eight preoperative covariates. The primary analysis employed overlap weighting (ATO), with multiple sensitivity analyses performed to assess robustness. Results: A total of 239 patients were included (TERPT, n = 181; Duhamel, n = 58). Before weighting, seven of eight covariates demonstrated meaningful imbalance (SMD > 0.10); ATO weighting achieved satisfactory balance across all covariates (all SMD < 0.10). A good composite outcome was achieved in 51.9% of TERPT and 53.4% of Duhamel patients, with no significant difference in the primary ATO-weighted analysis (OR 0.94, 95% CI 0.39–2.28; p = 0.897). No significant differences were observed in individual outcome components. Findings were consistent across all sensitivity analyses. TERPT was associated with significantly shorter operative time, lower estimated blood loss, and shorter hospital stay (all p < 0.001). Conclusions: No statistically significant differences were detected in 6-month postoperative functional outcomes between TERPT and the Duhamel operation. TERPT was associated with improved perioperative outcomes. However, these findings should be interpreted with caution due to limited statistical power and baseline differences between groups. Prospective multicenter studies with standardized outcome definitions and longer follow-up are warranted.
- 13 April 2026
- Published by MDPI AG in Pediatric Reports
- Vol. 18 (2) , 56
Open AccessComparison of Postoperative Outcomes of Duhamel and Transanal Endorectal Pull-Through in Hirschsprung Disease: A Propensity Score Study
Background/Objectives: Hirschsprung disease (HSCR) is a congenital condition characterized by absence of ganglion cells in the distal bowel. The principle of surgical treatment is resection of the aganglionic bowel with restoration of intestinal continuity. Several operative techniques have been developed. This study aimed to compare outcomes between the Duhamel procedure and transanal endorectal pull-through (TERPT) in Hirschsprung disease using propensity score-based methods. Methods: Hirschsprung patients who underwent Duhamel or TERPT from January 2006 to December 2021 were included. The primary outcome was a composite endpoint at 6 months comprising obstructive symptoms, fecal soiling, or Hirschsprung-associated enterocolitis. Propensity scores were estimated via logistic regression incorporating eight preoperative covariates. The primary analysis employed overlap weighting (ATO), with multiple sensitivity analyses performed to assess robustness. Results: A total of 239 patients were included (TERPT, n = 181; Duhamel, n = 58). Before weighting, seven of eight covariates demonstrated meaningful imbalance (SMD > 0.10); ATO weighting achieved satisfactory balance across all covariates (all SMD < 0.10). A good composite outcome was achieved in 51.9% of TERPT and 53.4% of Duhamel patients, with no significant difference in the primary ATO-weighted analysis (OR 0.94, 95% CI 0.39–2.28; p = 0.897). No significant differences were observed in individual outcome components. Findings were consistent across all sensitivity analyses. TERPT was associated with significantly shorter operative time, lower estimated blood loss, and shorter hospital stay (all p < 0.001). Conclusions: No statistically significant differences were detected in 6-month postoperative functional outcomes between TERPT and the Duhamel operation. TERPT was associated with improved perioperative outcomes. However, these findings should be interpreted with caution due to limited statistical power and baseline differences between groups. Prospective multicenter studies with standardized outcome definitions and longer follow-up are warranted.
- Top Cited PapersOpen Access
- 15 March 2026
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (3) , 214-227
Longitudinal analysis of gut microbiota dysbiosis and bacterial signatures predictive of postoperative enterocolitis in children with Hirschsprung disease
Background: We aimed to investigate differences in gut microbiota between patients with Hirschsprung disease (HSCR) and healthy children; assess longitudinal changes in the microbiota of patients with HSCR from diagnosis through postoperative period; and identify microbial markers predictive of postoperative HSCR-associated enterocolitis (HAEC).Purpose: To investigate alterations in the gut microbiota of patients with HSCR by assessing longitudinal microbiome changes after surgery and identifying microbial signatures predictive of postoperative HAECMethods: A case-control study of 20 patients with HSCR and 20 controls was conducted at Maharaj Nakorn Chiang Mai Hospital. Fecal specimens were collected from patients with HSCR at initial diagnosis and from age-matched controls. Additional samples were obtained from patients intraoperatively and at 1 and 6 months postoperatively. A microbial analysis was performed using 16S rRNA gene sequencing (V3–V4 hypervariable regions).Results: Compared to controls, patients with HSCR exhibited gut dysbiosis characterized by reduced microbial diversity and altered community composition as determined by Analysis of Compositions of Microbiomes with Bias Correction. Increased relative abundances of Robinsoniella, Fusobacterium, Cutibacterium, Citrobacter, and Eubacterium fissicatena were observed in patients with HSCR, whereas NK4A214, Lachnospiraceae XPB1014 groups, Acinetobacter and Acetitomaculum were decreased (q< 0.05). Alpha diversity in patients with HSCR was significantly increased at 6 months postoperatively versus at theinitial diagnosis (P<0.05). Longitudinal changes in Eubacterium and Eubacteriales suggest their potential use as markers of treatment efficacy. In patients who developed postoperative HAEC, Olsenella was enriched in the proximal intestine, whereas Holdemanella, Corynebacterium, Collinsella, and CAG-352 were elevated in the distal intestine (q<0.05).Conclusion: Patients with HSCR exhibited distinct alterations in the gut microbiota, with significant shifts observed between the pretreatment period and 6 months postoperatively. Specific bacterial taxa were identified as potential markers for HAEC development. Future microbiome-targeted interventions to prevent HAEC need to be explored.
- 15 March 2026
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (3) , 214-227
Top Cited PapersOpen AccessLongitudinal analysis of gut microbiota dysbiosis and bacterial signatures predictive of postoperative enterocolitis in children with Hirschsprung disease
Background: We aimed to investigate differences in gut microbiota between patients with Hirschsprung disease (HSCR) and healthy children; assess longitudinal changes in the microbiota of patients with HSCR from diagnosis through postoperative period; and identify microbial markers predictive of postoperative HSCR-associated enterocolitis (HAEC).Purpose: To investigate alterations in the gut microbiota of patients with HSCR by assessing longitudinal microbiome changes after surgery and identifying microbial signatures predictive of postoperative HAECMethods: A case-control study of 20 patients with HSCR and 20 controls was conducted at Maharaj Nakorn Chiang Mai Hospital. Fecal specimens were collected from patients with HSCR at initial diagnosis and from age-matched controls. Additional samples were obtained from patients intraoperatively and at 1 and 6 months postoperatively. A microbial analysis was performed using 16S rRNA gene sequencing (V3–V4 hypervariable regions).Results: Compared to controls, patients with HSCR exhibited gut dysbiosis characterized by reduced microbial diversity and altered community composition as determined by Analysis of Compositions of Microbiomes with Bias Correction. Increased relative abundances of Robinsoniella, Fusobacterium, Cutibacterium, Citrobacter, and Eubacterium fissicatena were observed in patients with HSCR, whereas NK4A214, Lachnospiraceae XPB1014 groups, Acinetobacter and Acetitomaculum were decreased (q< 0.05). Alpha diversity in patients with HSCR was significantly increased at 6 months postoperatively versus at theinitial diagnosis (P<0.05). Longitudinal changes in Eubacterium and Eubacteriales suggest their potential use as markers of treatment efficacy. In patients who developed postoperative HAEC, Olsenella was enriched in the proximal intestine, whereas Holdemanella, Corynebacterium, Collinsella, and CAG-352 were elevated in the distal intestine (q<0.05).Conclusion: Patients with HSCR exhibited distinct alterations in the gut microbiota, with significant shifts observed between the pretreatment period and 6 months postoperatively. Specific bacterial taxa were identified as potential markers for HAEC development. Future microbiome-targeted interventions to prevent HAEC need to be explored.
- Open Access
- 13 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2204
Propensity Score Analysis of Second-Line Chemotherapy Outcome in Advanced Biliary Tract Cancer
Background/Objectives: Several chemotherapeutic regimens and targeted therapies are currently established as standard second-line treatments for patients with advanced biliary tract cancer (BTC). However, evidence regarding the benefits of treatment after first-line therapy failure remains limited, particularly among Thai populations. This study aimed to explore the efficacy of second-line chemotherapy in patients with advanced BTC. Methods: We conducted a single-institution, retrospective study including patients with locally advanced or metastatic BTC who experienced disease progression following first-line treatment between January 2017 and December 2019. Overall survival (OS) was defined as the primary endpoint. The secondary endpoint was the restricted mean survival time (RMST). To minimize confounding, propensity scores were estimated and applied using inverse probability of treatment weighting (IPTW). Results: A total of 110 patients were included, of whom 69 (62%) received second-line chemotherapy in combination with best supportive care (2LCMT + BSC), while 41 (38%) received best supportive care (BSC) alone. The majority of cases were intrahepatic cholangiocarcinoma (73.9% and 70.7% in each group, respectively). The median OS was 5.3 months (95% CI 3.5–7.0) in the 2LCMT + BSC group and 1.0 months (95% CI 0.5–1.9) in the BSC-only group (unadjusted HR 0.40, 95% CI 0.26–0.59; p < 0.001). In IPTW-adjusted flexible parametric regression analysis, second-line chemotherapy was associated with a 53% reduction in the risk of death compared with BSC alone (p = 0.009). The restricted mean survival time (RMST) differences between groups at 3, 6, and 12 months were 1.3 months (95% CI 0.9–1.6; p < 0.001), 2.6 months (95% CI 1.9–3.3; p < 0.001), and 3.9 months (95% CI 2.7–5.1; p < 0.001), sequentially. Conclusions: These findings demonstrate that second-line chemotherapy provides a significant overall survival benefit compared with best supportive care alone in patients with advanced BTC.
- 13 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2204
Open AccessPropensity Score Analysis of Second-Line Chemotherapy Outcome in Advanced Biliary Tract Cancer
Background/Objectives: Several chemotherapeutic regimens and targeted therapies are currently established as standard second-line treatments for patients with advanced biliary tract cancer (BTC). However, evidence regarding the benefits of treatment after first-line therapy failure remains limited, particularly among Thai populations. This study aimed to explore the efficacy of second-line chemotherapy in patients with advanced BTC. Methods: We conducted a single-institution, retrospective study including patients with locally advanced or metastatic BTC who experienced disease progression following first-line treatment between January 2017 and December 2019. Overall survival (OS) was defined as the primary endpoint. The secondary endpoint was the restricted mean survival time (RMST). To minimize confounding, propensity scores were estimated and applied using inverse probability of treatment weighting (IPTW). Results: A total of 110 patients were included, of whom 69 (62%) received second-line chemotherapy in combination with best supportive care (2LCMT + BSC), while 41 (38%) received best supportive care (BSC) alone. The majority of cases were intrahepatic cholangiocarcinoma (73.9% and 70.7% in each group, respectively). The median OS was 5.3 months (95% CI 3.5–7.0) in the 2LCMT + BSC group and 1.0 months (95% CI 0.5–1.9) in the BSC-only group (unadjusted HR 0.40, 95% CI 0.26–0.59; p < 0.001). In IPTW-adjusted flexible parametric regression analysis, second-line chemotherapy was associated with a 53% reduction in the risk of death compared with BSC alone (p = 0.009). The restricted mean survival time (RMST) differences between groups at 3, 6, and 12 months were 1.3 months (95% CI 0.9–1.6; p < 0.001), 2.6 months (95% CI 1.9–3.3; p < 0.001), and 3.9 months (95% CI 2.7–5.1; p < 0.001), sequentially. Conclusions: These findings demonstrate that second-line chemotherapy provides a significant overall survival benefit compared with best supportive care alone in patients with advanced BTC.
- Open Access
- 1 February 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (2) , 70
Predictors and clinical outcomes of acute kidney injury after thoracic surgery: a retrospective cohort study
Background: Acute kidney injury (AKI), defined as a rapid decline of renal function, is a frequent complication observed after major surgical procedures. In patients undergoing thoracic surgery, the reported incidence of AKI ranges from 5% to 15%. The development of AKI is associated with an elevated risk of postoperative complications, including the need for reintubation, longer hospital admissions, and higher mortality rates. During one-lung ventilation (OLV), intraoperative hypoxemia and hypercarbia, along with systemic inflammation induced by alveolar over-distension, can contribute to decreased renal perfusion, which may ultimately result in AKI. This study aims to determine the incidence, identify predictive factors, and evaluate the clinical outcomes associated with AKI following thoracic surgery. Methods: In retrospective cohort study, all consecutive patients aged 18 years and over undergoing non-cardiac thoracic surgery at a tertiary university hospital between 2012 and 2021 were enrolled. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO)-2012. The univariable and multivariable logistic regression were analyzed and presented as odds ratio (OR) and 95% confidence interval (CI). A Kaplan-Meier curve and log-rank test were used for comparison of hospital mortality between patients with or without AKI. Results: The incidence of AKI was 23.9% (318 of 1,329 patients), with cases classified as stage I (184, 13.8%), stage II (115, 8.7%), or stage III (19, 1.4%) according to the KDIGO criteria. In the multivariable logistic regression analysis, age ≥70 years (OR, 1.74; 95% CI: 1.21–2.50, P=0.003), body mass index (BMI) >25 kg/m2 (OR, 2.39; 95% CI: 1.73–3.36; Pvs. 0 (0–1) days, P=0.001], longer hospital stays {14.5 [9–24] vs. 9 [6–18] days, P=0.005}, and an increased mortality rate (10.1% vs. 5%, P=0.001) compared to those without AKI. Patients with stage III AKI had a significantly higher 30-day mortality rate compared to other stages (PConclusions: The findings of this study highlight important predictors for AKI in patients undergoing thoracic surgery. Recognizing these predictors early may support timely interventions and the development of strategies aimed at reducing the likelihood of AKI, thereby promoting better postoperative recovery.
- 1 February 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (2) , 70
Open AccessPredictors and clinical outcomes of acute kidney injury after thoracic surgery: a retrospective cohort study
Background: Acute kidney injury (AKI), defined as a rapid decline of renal function, is a frequent complication observed after major surgical procedures. In patients undergoing thoracic surgery, the reported incidence of AKI ranges from 5% to 15%. The development of AKI is associated with an elevated risk of postoperative complications, including the need for reintubation, longer hospital admissions, and higher mortality rates. During one-lung ventilation (OLV), intraoperative hypoxemia and hypercarbia, along with systemic inflammation induced by alveolar over-distension, can contribute to decreased renal perfusion, which may ultimately result in AKI. This study aims to determine the incidence, identify predictive factors, and evaluate the clinical outcomes associated with AKI following thoracic surgery. Methods: In retrospective cohort study, all consecutive patients aged 18 years and over undergoing non-cardiac thoracic surgery at a tertiary university hospital between 2012 and 2021 were enrolled. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO)-2012. The univariable and multivariable logistic regression were analyzed and presented as odds ratio (OR) and 95% confidence interval (CI). A Kaplan-Meier curve and log-rank test were used for comparison of hospital mortality between patients with or without AKI. Results: The incidence of AKI was 23.9% (318 of 1,329 patients), with cases classified as stage I (184, 13.8%), stage II (115, 8.7%), or stage III (19, 1.4%) according to the KDIGO criteria. In the multivariable logistic regression analysis, age ≥70 years (OR, 1.74; 95% CI: 1.21–2.50, P=0.003), body mass index (BMI) >25 kg/m2 (OR, 2.39; 95% CI: 1.73–3.36; Pvs. 0 (0–1) days, P=0.001], longer hospital stays {14.5 [9–24] vs. 9 [6–18] days, P=0.005}, and an increased mortality rate (10.1% vs. 5%, P=0.001) compared to those without AKI. Patients with stage III AKI had a significantly higher 30-day mortality rate compared to other stages (PConclusions: The findings of this study highlight important predictors for AKI in patients undergoing thoracic surgery. Recognizing these predictors early may support timely interventions and the development of strategies aimed at reducing the likelihood of AKI, thereby promoting better postoperative recovery.
- Open Access
- 7 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 464
Effects of Frenulotomy on Outcomes Associated with Breastfeeding Practice
Background/Objectives: This study aimed to evaluate the effects of frenulotomy in mother–infant pairs with problematic tongue-tie. Methods: A 2-year prospective observational cohort study was performed. Mother–infant pairs were divided into frenulotomy and non-frenulotomy groups by maternal choice. Four breastfeeding practice outcomes were evaluated: reduced latching pain scores, improved LATCH scores, regained birth weight within 2 weeks post-partum, and successful exclusive breastfeeding (EBF) at 3 months of age. The comparison between groups was performed using multivariable risk regression with propensity score analysis. Results: A total of 350 mother–infant pairs were included. There were 226 mother–infant pairs who underwent frenulotomy and 124 pairs in the non-frenulotomy group. The median latching pain scores significantly decreased from 6 to 3 at 24 h post-operatively and from 6 to 0 at 1 week post-operatively (p < 0.001). The median LATCH scores increased significantly from 5 to 9 at 1 week post-operatively (p < 0.001). LATCH scores within 2 weeks were improved in the frenolotomy group (risk ratio = 1.31, p = 0.017). The success rate of EBF at 3 months was 72.12% in the frenulotomy group and 76.61% in the non-frenulotomy group, with no statistically significance. Conclusions: Short-term breastfeeding outcomes and LATCH scores in mother–infant pairs with tongue-tie improved faster in those who underwent the procedure, with no complications.
- 7 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 464
Open AccessEffects of Frenulotomy on Outcomes Associated with Breastfeeding Practice
Background/Objectives: This study aimed to evaluate the effects of frenulotomy in mother–infant pairs with problematic tongue-tie. Methods: A 2-year prospective observational cohort study was performed. Mother–infant pairs were divided into frenulotomy and non-frenulotomy groups by maternal choice. Four breastfeeding practice outcomes were evaluated: reduced latching pain scores, improved LATCH scores, regained birth weight within 2 weeks post-partum, and successful exclusive breastfeeding (EBF) at 3 months of age. The comparison between groups was performed using multivariable risk regression with propensity score analysis. Results: A total of 350 mother–infant pairs were included. There were 226 mother–infant pairs who underwent frenulotomy and 124 pairs in the non-frenulotomy group. The median latching pain scores significantly decreased from 6 to 3 at 24 h post-operatively and from 6 to 0 at 1 week post-operatively (p < 0.001). The median LATCH scores increased significantly from 5 to 9 at 1 week post-operatively (p < 0.001). LATCH scores within 2 weeks were improved in the frenolotomy group (risk ratio = 1.31, p = 0.017). The success rate of EBF at 3 months was 72.12% in the frenulotomy group and 76.61% in the non-frenulotomy group, with no statistically significance. Conclusions: Short-term breastfeeding outcomes and LATCH scores in mother–infant pairs with tongue-tie improved faster in those who underwent the procedure, with no complications.